Stocks Express Scripts Holding Co

More

  • Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • ST. LOUIS _ Express Scripts Holding Co. on Monday reported first-quarter profit of $526.1 million. Ten analysts surveyed by Zacks expected $25.52 billion. For the current quarter ending in July, Express Scripts expects its per-share earnings to range from $1.55 to $1.59.

  • CNBC Mad Money Lightning Round

    Jim Cramer provides his opinion on caller stocks at a rapid pace, including this high-flying tech stock.

  • Prescription drugs

    Presidential candidates may talk about combating high drug prices, but Express Scripts' Dr. Steve Miller says it takes more than talk to make it work.

  • Anthem CEO: ANTM/CI deal in not too distant future

    Joseph Swedish, CEO at Anthem, talks about his company's on-going deal to buy Cigna, the outlook for Anthem in Obamacare exchanges, and working toward affordable drug prices.

  • Street Talk: CBRL, IMAX, ESRX, CRM & WCG

    "Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Telsey Advisory upgrading Cracker Barrel to outperform, and a bullish note on Salesforce.com.

  • A trader on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stock futures were higher this morning, putting the Dow and S&P 500 on track for a third day of gains, and the Nasdaq for a second straight positive day after breaking an eight-session losing streak.

  • A pedestrian passes in front of the Pfizer headquarters in New York City.

    Adding large-cap names to your portfolio.

  • NEW YORK, Dec 23- The recent pact between Valeant Pharmaceuticals International and Walgreens Boots Alliance may salvage the drugmaker's relationships with physicians, but is unlikely to fully restore Valeant's previous revenue growth from high-priced, branded drugs, according to doctors and investors. Under the deal announced last week, Walgreen's will...

  • NEW YORK, Dec 23- A new class of blood thinners that competes with widely used warfarin should get a boost next year when an "antidote" that can reverse the medications' effects in an emergency is expected to enter the market, according to top U.S. heart doctors and investors. Xarelto, from Bayer AG and Johnson& Johnson, and Eliquis, sold by Bristol-Myers Squibb and...

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed higher Tuesday, helped by some stabilization in oil prices and recovery in hard-hit areas of the market this year.

  • Dec 22- Pharmacy benefit manager Express Scripts Holding Co said it was negotiating the repricing of its contract with Anthem Inc, one of its biggest customers, but it was too soon to know the financial terms of the deal. Express Scripts made the disclosure during a conference call to discuss its growth outlook for 2016, which was above analysts' estimates.

  • *Express Scripts up after 2016 profit forecast. Dec 22- U.S. stock indexes were set to open slightly higher on Tuesday as third-quarter GDP growth beat estimates and crude oil prices edged up from multi-year lows. "I think the main thing that markets are going to be looking at today is the whole deal with oil," said Matthew Tuttle, chief executive, Tuttle Tactical...

  • Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Dec 22- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, forecast adjusted earnings for 2016 well above analysts' estimates. Shares of Express Scripts, which manages drug benefits for employers and health plans and also runs large mail-order pharmacies, were up 1 percent in light premarket trading. The company has become a vocal critic of...

  • Dec 22- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said it expected 2016 adjusted earnings of $6.08- $6.28 per share, an increase of 10-14 percent from the company's reaffirmed guidance for 2015.. Analysts were expecting full-year adjusted earnings of $6.04 per share, according to Thomson Reuters I/B/E/S. Express Scripts manages...

  • *Deal with Walgreens more than replaces Philidor-Valeant CEO. Dec 15- Valeant Pharmaceuticals International Inc on Tuesday said it reached a deal to distribute its drugs through leading pharmacy chain Walgreens Boots Alliance Inc, boosting credibility with wary investors and sending its shares up 17 percent. The company said on Tuesday its arrangement...